LivaNova (NASDAQ:LIVN) Upgraded at StockNews.com

LivaNova (NASDAQ:LIVN) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Tuesday.

Other analysts have also issued research reports about the stock. Stifel Nicolaus decreased their price target on shares of LivaNova from $72.00 to $60.00 and set a “buy” rating for the company in a research note on Wednesday, February 26th. Wolfe Research lowered shares of LivaNova from an “outperform” rating to a “peer perform” rating in a report on Wednesday, February 26th. Barclays cut their price target on LivaNova from $58.00 to $56.00 and set an “equal weight” rating for the company in a research note on Friday, March 7th. Needham & Company LLC reissued a “buy” rating and issued a $64.00 price objective on shares of LivaNova in a research note on Monday, March 17th. Finally, Mizuho cut their target price on LivaNova from $70.00 to $60.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating, five have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $61.17.

LivaNova Trading Down 0.1 %

Shares of LivaNova stock opened at $39.90 on Tuesday. The stock has a market capitalization of $2.17 billion, a PE ratio of 95.00 and a beta of 1.10. LivaNova has a 52 week low of $36.85 and a 52 week high of $64.48. The stock has a 50 day moving average price of $44.86 and a two-hundred day moving average price of $48.58. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37.

Hedge Funds Weigh In On LivaNova

Several institutional investors have recently modified their holdings of LIVN. Russell Investments Group Ltd. lifted its holdings in LivaNova by 17.1% during the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock worth $70,000 after acquiring an additional 219 shares during the period. Sterling Capital Management LLC increased its position in shares of LivaNova by 800.6% during the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock valued at $75,000 after purchasing an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division raised its stake in shares of LivaNova by 21.2% during the 4th quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock worth $191,000 after purchasing an additional 720 shares during the period. Vestcor Inc purchased a new position in shares of LivaNova in the 4th quarter worth about $204,000. Finally, Optimize Financial Inc purchased a new position in shares of LivaNova in the 4th quarter worth about $208,000. 97.64% of the stock is owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.